Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B

類似資料

• Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling
  著者:: Dahari, Harel, 等
  出版事項: (2012)
• Understanding the nature of early HCV RNA blips and the use of mathematical modeling of viral kinetics during IFN-based therapy
  著者:: Guedj, Jeremie, 等
  出版事項: (2011)
• Mathematical modeling of HCV infection: what can it teach us in the era of direct antiviral agents?
  著者:: Chatterjee, Anushree, 等
  出版事項: (2012)
• IL28B-Genotype Testing Now and in the Era of Direct-Acting Antiviral Agents
  著者:: Morgan, Timothy R., 等
  出版事項: (2010)
• The Role of IL28B Genotype Testing in the Era of Direct Acting Antiviral Agents
  著者:: Osinusi, Anu, 等
  出版事項: (2012)